No data support the efficacy of currently marketed patches
This is where most dosing errors happen
(2024) Bendotti G, Montefusco L, Lunati ME, Usuelli V, Pastore I, Lazzaroni E, et al (2022) The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists
How Your Genetics Relate to GLP-1 Pathways Your baseline lipid panel and metabolic biomarkers provide crucial context for predicting potential GLP-1 treatment effects
Retatrutide targets three hormone receptors (GLP-1, GIP, and Glucagon) simultaneously, and this broader mechanism may explain why skin-related reactions appear more often compared to single-receptor treatments
Ozempic is semaglutide, a GLP-1 receptor agonist